Shenzhen YHLO Biotech Co (SHSE:688575) ROCE %: 2.63% (As of Mar. 2026)


SHSE:688575 Shenzhen YHLO Biotech Co Ltd SHSE:688575
64 GF Score
Price ¥9.17
GF Value ¥14.47
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shenzhen YHLO Biotech Co ROCE %?

Shenzhen YHLO Biotech Co SHSE:688575 +0.66% 64 ROCE % is 2.63% as of Mar. 2026. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.47 (Significantly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shenzhen YHLO Biotech Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 2.63%.

Shenzhen YHLO Biotech Co  (SHSE:688575) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shenzhen YHLO Biotech Co ROCE % Related Terms

Shenzhen YHLO Biotech Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shenzhen YHLO Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen YHLO Biotech Co ROCE % Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 19.68 55.51 12.06 10.25 3.49

Shenzhen YHLO Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 2.41 5.55 4.60 2.63
SHSE:688575
64GF Score
Shenzhen YHLO Biotech Co Ltd SHSE:688575
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen YHLO Biotech Co ROCE % Calculation

Shenzhen YHLO Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=117.363/( ( (4415.093 - 1057.705) + (4288.73 - 924.27) )/ 2 )
=117.363/( (3357.388+3364.46)/ 2 )
=117.363/3360.924
=3.49 %

Shenzhen YHLO Biotech Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=88.988/( ( (4288.73 - 924.27) + (4300.88 - 907.158) )/ 2 )
=88.988/( ( 3364.46 + 3393.722 )/ 2 )
=88.988/3379.091
=2.63 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.63% mean?
Shenzhen YHLO Biotech Co (SHSE:688575) has a ROCE % of 2.63% as of Mar. 2026.
Is Shenzhen YHLO Biotech Co's ROCE % too high?
Shenzhen YHLO Biotech Co's current ROCE % is 2.63%. The Medical Devices & Instruments industry median ROCE % is 2.20. Shenzhen YHLO Biotech Co's value of 2.63% is 19.5% above this industry median. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's ROCE % compare to ABT and SYK?
Shenzhen YHLO Biotech Co's ROCE % of 2.63% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Shenzhen YHLO Biotech Co's value of 2.63% is 19.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen YHLO Biotech Co's current ROCE % of 2.63% is 19.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current ROCE % is 2.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.47, compared to a current price of ¥9.17 — trading 36.6% below its estimated fair value. The current ROCE % is 2.63% and 19.5% above the Medical Devices & Instruments industry median of 2.20. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current ROCE % is 2.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued. The current stock price of ¥9.17 is trading 36.6% below its estimated GF Value™ of ¥14.47. GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688575:

  • ROCE %: 2.63%
  • GF Value™: ¥14.47 vs. price of ¥9.17 (36.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs
  • Industry Position: 19.5% above the Medical Devices & Instruments median

No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen YHLO Biotech Co Business Description

Address Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biotechnology Factory Area, Longgang District, Guangdong Province, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score

Get the complete analysis for SHSE:688575

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.17
Price
¥14.47
GF Value